2017 annual financial data
Marker Therapeutics 2017 Net margin
Marker Therapeutics 2017 net margin with verified reported values.
Direct answer
Net margin was -5,998.99%.
Operating income was -11,480,000 USD and net income was -10,982,000 USD.
Operating cash flow was -8,439,427 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 183,064 USD
- Operating income
- -11,480,000 USD
- Net income
- -10,982,000 USD
- Operating cash flow
- -8,439,427 USD